1 Min Read
Feb 22 (Reuters) - Gilead Sciences Canada
* Gilead Sciences Canada- effective feb 28, ontario to list epclusa on public drug plan to treat all six genotypes of chronic hepatitis c infection Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.